Octreotide February 8, 2015[email protected] Octreotide Trade Name Sandostatin Lar Orphan Indication VIPoma USA Market Approval USA USA Designation Date 1998-08-24 00:00:00 Sponsor Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936
